跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
cannabinoid derivative
首页
药物
cannabinoid derivative
cannabinoid derivative
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same
US 11872259 B2
申请人: NOEL ARMAND J
优先权: 2021
US
WO
8 件公开
CHEWING GUM COMPOSITIONS COMPRISING CANNABINOIDS
US 2011097283 A1
申请人: MAREDA HOLDING BV
优先权: 2008
US
WO
5 件公开
Resorcinol derivatives
US 9254272 B2
申请人: SUTTER WEST BAY HOSPITALS
优先权: 2012
US
5 件公开
COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS
EP 4232017 A1
申请人: INMED PHARMACEUTICALS INC
优先权: 2020
CN
EP
US
WO
4 件公开
COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS
EP 4003395 A4
申请人: CAAMTECH INC
优先权: 2019
EP
US
WO
4 件公开
CANNABINOID DERIVATIVE AS A PHARMACEUTICALLY ACTIVE COMPOUND AND METHOD OF PREPARATION THEREOF
EP 4262979 B1
申请人: JAZZ PHARMACEUTICALS RESEARCH UK LTD
优先权: 2020
EP
US
WO
4 件公开
Pyrimidine compound
US 8524727 B2
申请人: MATSUSHIMA YUJI
优先权: 2009
CN
US
4 件公开
Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
US 6432984 B1
申请人: SANOFI SYNTHELABO
优先权: 1999
US
4 件公开
Use for Cannabinoid
US 2009306221 A1
申请人: GW PHARMA LTD
优先权: 2006
EP
US
WO
3 件公开
COMPOSITIONS AND METHODS COMPRISING A PSILOCYBIN DERIVATIVE
EP 3579832 A4
申请人: CAAMTECH LLC
优先权: 2017
CN
EP
US
3 件公开
第 1 / 7 页
上一页
下一页
药物
反馈